Overcoming roadblocks in the development of vaccines for leishmaniasis-Reference-Cited by-同舟云学术

Overcoming roadblocks in the development of vaccines for leishmaniasis

Published:2021-11-02 Issue:11 Volume:20 Page:1419-1430
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Kaye Paul M.¹^ORCID,Mohan Sakshi²,Mantel Carsten³,Malhame Melissa³,Revill Paul²^ORCID,Le Rutte Epke⁴⁵,Parkash Vivak¹,Layton Alison M.¹,Lacey Charles J.N.¹,Malvolti Stefano³^ORCID

Affiliation:

1. York Biomedical Research Institute, Hull York Medical School, University of York, Heslington, York, UK

2. Centre for Health Economics, University of York, Heslington, York, UK

3. MMGH Consulting, Zurich, Switzerland

4. Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland

5. Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands

Funder

Wellcome Trust Senior Investigator Award

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1990043

Reference109 articles.

1. Leishmaniasis Worldwide and Global Estimates of Its Incidence

2. Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives

3. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

4. The impact of leishmaniasis on mental health and psychosocial well-being: A systematic review

5. Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico and experimental potentials of 6-shogaol and meglumine antimoniate on Leishmania major: multiple synergistic combinations through modulation of biological properties;Immunologic Research;2024-08-18

2. Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis;Nature Medicine;2024-08-02

3. mRNA vaccines against infectious diseases and future direction;International Immunopharmacology;2024-06

4. Targeting Leishmania infantum Mannosyl-oligosaccharide glucosidase with natural products: potential pH-dependent inhibition explored through computer-aided drug design;Frontiers in Pharmacology;2024-05-30

5. Safety, effectiveness, and skin immune response in a controlled human infection model of sand fly transmitted cutaneous leishmaniasis;2024-04-13